26.45

1.34% -0.36

After Hours: 26.31 -0.14 -0.53%

Stevanato Group Spa (STVN)

Overview News Price History Option Chain Why STVN Down? Discussions Forecast Dividend History

Stevanato Group Spa stock is currently priced at $26.45, with a 24-hour trading volume of 277.66K. It has seen a -1.34% decreased in the last 24 hours and a -12.10% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $27.24 pivot point. If it approaches the $25.85 support level, significant changes may occur.

Previous Close:

$26.81

Open:

$27.19

24h Volume:

277.66K

Market Cap:

$7.21B

Revenue:

$1.17B

Net Income/Loss:

$157.66M

P/E Ratio:

44.35

EPS:

0.5964

Net Cash Flow:

$-364.54M

1W Performance:

-3.96%

1M Performance:

-12.10%

6M Performance:

-0.82%

1Y Performance:

-4.79%

1D Range:

$26.04

$27.72

52W Range:

$23.00

$36.30

Stevanato Group Spa Stock (STVN) Company Profile

Name

Stevanato Group Spa

Sector

Healthcare (1213)

Industry

Medical Instruments & Supplies (60)

Phone

39 0499 31 81 11

Address

Via Molinella, 17, Piombino Dese

Employee

4,344

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

STVN's Discussions on Twitter

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-01-23	Downgrade	Jefferies	Buy → Hold
Sep-26-23	Initiated	Stephens	Overweight
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-10-21	Initiated	BofA Securities	Buy
Aug-10-21	Initiated	Citigroup	Buy
Aug-10-21	Initiated	Jefferies	Buy
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight
Aug-10-21	Initiated	Morgan Stanley	Overweight
Aug-10-21	Initiated	Wells Fargo	Overweight

View All

Stevanato Group Spa Stock (STVN) Latest News

USNA or STVN: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Stevanato Group (STVN) to Report Q1 Results: What You Should Expect

Zacks Investment Research

TAK or STVN: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Stevanato Group Spa Stock (STVN) Financials Data

Stevanato Group Spa (STVN) Revenue 2024

STVN reported a revenue (TTM) of $1.17 billion for the quarter ending December 31, 2023, a +13.70% rise year-over-year.

Stevanato Group Spa (STVN) Net Income 2024

STVN net income (TTM) was $157.66 million for the quarter ending December 31, 2023, a +5.40% increase year-over-year.

Stevanato Group Spa (STVN) Cash Flow 2024

STVN recorded a free cash flow (TTM) of -$364.54 million for the quarter ending December 31, 2023, a -147.23% decrease year-over-year.

Stevanato Group Spa (STVN) Earnings per Share 2024

STVN earnings per share (TTM) was $0.5954 for the quarter ending December 31, 2023, a +5.36% growth year-over-year.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.